u/ayesha_erdogan

Yes — the day-two-to-day-four window is so consistent across this board that it is almost diagnostic.

compare cash prices before assuming coverage is the only path

Nothing in this thread is medical advice, including this comment. I am describing a mechanism, not telling anybody what to do about their own week.

Went and read the primary rodent papers after arguing about a summary for a week. They are much narrower than the threads suggest.

A rejected claim at the pharmacy counter and a denied authorization are different events with different remedies. The first can be an administrative or quantity issue; the second is a determination you can appeal.

Same view. The analytical problem is different enough that the usual purity discussions here do not transfer cleanly.

pentadecapeptide, fifteen residues, and the sequence is public

Cosigning that the papers are more modest than the summaries of them. That is true across this whole site and especially here.

What method produced that purity number?

sulphur burps are unpleasant and they are not dangerous

Disagree. Severe abdominal pain is not on the list of things to wait out, and this board should not be treating it as one.

the same product can be covered in one province and not the next

Has anything else changed in the same window?

write down when it starts and stops, the pattern is the useful part

hair shedding follows the weight loss, not the drug, and it stops

The pattern almost everyone here describes, written out once so it can be linked.

Agreed, with the caveat that "usually settles" is not "always settles" and the exceptions should still get asked about properly.

Compared milligram figures across two completely different molecule classes in a comment. Deserved the correction.

Bought four different things to fix my constipation. What actually worked was eating half as fast.

Purity by area percent tells you the sample is homogeneous. Mass spectrometry tells you what the homogeneous thing is. For a short peptide, the second question is the one worth paying for.

Correction: that is the oral peptide product, which is a different thing entirely. This one is a small molecule.

the manufacturing story is genuinely different from the injectables

This is the fact the whole board hangs on. Small molecule, not peptide.

Cosigning on quantity limits. They stop as many people as outright denials do and get discussed far less.

pentadecapeptide, fifteen residues, and the sequence is public

reflux at night, try not eating in the three hours before bed

Nothing here is medical or legal advice. The pharmacist and the prescriber are the people who can act, and both are faster than a forum.

pentadecapeptide, fifteen residues, and the sequence is public

Disagree. You are comparing doses across a small molecule and a peptide, which is not a comparison of anything.

Read both programme names carefully after mixing them up in a comment and being politely corrected.

nothing containing this is approved anywhere and research material is not for human use

The pharmacist sorted in five minutes what the phone line had not managed in a fortnight.

Held the dose for an extra six weeks instead of stepping. The reflux settled and I lost the same amount anyway.

Small fix — that formulary position is another province’s and does not apply here.

Confused a rejected claim with a denied authorization for a month and pursued entirely the wrong process.

This is why every thread here needs a province in it.

Nothing in this thread is medical advice, including this comment. I am describing a mechanism, not telling anybody what to do about their own week.

a rough fortnight at each step is normal, a rough three months is not

do not assume reconstitution intuitions apply, there is nothing to reconstitute

Are you eating in the couple of hours before you sleep?

Kept a one-line-a-day log for two months. The pattern was obvious on paper and invisible in my head.